Dyslipidemia Treatment in Malaysia
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Dyslipidemia?
Dyslipidemia is a condition in which the levels of fats (lipids) in the blood are abnormal. This may include high levels of LDL (“bad”) cholesterol or triglycerides, low levels of HDL (“good”) cholesterol, or a combination of these changes. Dyslipidemia can increase the risk of atherosclerotic cardiovascular disease (ASCVD), including heart attack and stroke. Some lipid abnormalities are inherited, while others are linked to diet, obesity, diabetes, kidney disease, thyroid disorders, medications, or other medical conditions.
What is the Importance of Timely Treatment?
Timely diagnosis and management of dyslipidemia can reduce long-term exposure to atherogenic lipoproteins and lower the risk of cardiovascular complications. Dyslipidemia often causes no noticeable symptoms, so routine lipid testing and overall cardiovascular risk assessment are important. Treatment may involve lifestyle changes, statins, other lipid-lowering medicines, and management of underlying conditions.
What are the Common Symptoms of Dyslipidemia?
- Xanthelasma: Yellowish cholesterol deposits around the eyes or eyelids
- Tendon xanthomas: Firm deposits of cholesterol in tendons, sometimes associated with inherited lipid disorders.
- Corneal arcus: A pale or grey ring around the edge of the cornea. When present at a younger age, it may warrant assessment for an underlying lipid disorder.
- Symptoms of cardiovascular disease: If atherosclerosis develops, you may experience chest discomfort, breathlessness, or leg pain during walking. These symptoms require medical assessment and are not specific to dyslipidemia.
- Symptoms of pancreatitis: Very high triglyceride levels can cause acute pancreatitis, which may present with severe abdominal pain, nausea, and vomiting and requires urgent medical care.
Causes and Risk Factors of Dyslipidemia
Causes
- Dyslipidemia may result from inherited genetic abnormalities, lifestyle factors, medical conditions, or medicines.
- Common contributors include diets high in saturated fats, excess body weight, physical inactivity, diabetes, hypothyroidism, chronic kidney disease, liver disease, and certain medicines.
- Familial hypercholesterolemia and other inherited lipid disorders can cause markedly elevated cholesterol levels from an early age.
Risk Factors
- Family history of high cholesterol or premature cardiovascular disease
- Unhealthy dietary patterns, particularly high intake of saturated or trans fats
- Physical inactivity
- Overweight or obesity
- Type 2 diabetes
- Metabolic syndrome
- Hypothyroidism
- Chronic kidney disease
- Liver disease
- Certain hormonal or metabolic disorders
- Smoking
- Excessive alcohol intake, particularly in hypertriglyceridemia
- Certain medicines
- Familial hypercholesterolemia or other inherited lipid disorders
- Increasing age
- Previous cardiovascular disease
Latest Research and Technologies in the Treatment of Dyslipidemia in Malaysia
- Recent Malaysian research has highlighted the need to improve cholesterol control in people at high cardiovascular risk. Advances in dyslipidaemia management include personalised cardiovascular risk assessment, testing for additional markers such as lipoprotein(a) when appropriate, and combining lipid-lowering treatments when needed to achieve cholesterol targets. Malaysia's clinical practice guidelines recommend risk assessment and treatment, while access to specialised testing and newer therapies varies between centres.
Treatment options for Dyslipidemia
Sleeve gastrectomy : A highly effective treatment for managing lipid disorders, it can lead to complete resolution or significant improvement of dyslipidemia. The surgery achieves its metabolic impact mainly through substantial weight loss and a severe reduction in calorie intake, which lowers systemic insulin resistance and reduces the liver's overproduction of triglycerides.
Cost Start From 7500Explore Options
- Clinical assessment:
- Medical and Family History: Evaluation includes dietary habits, physical activity, body weight, smoking, alcohol intake, medications, previous lipid results, diabetes, kidney or thyroid disease, liver disease, cardiovascular history, and family history of high cholesterol or premature ASCVD.
- Physical Examination: The examination may assess blood pressure, body weight, waist circumference, cardiovascular findings, and signs of severe lipid disorders.
- Lipid Profile Assessment: A lipid panel generally evaluates total cholesterol, LDL-C, HDL-C, and triglycerides. Non-HDL cholesterol can provide additional information about atherogenic lipoproteins and is particularly useful when triglycerides are elevated.
- Cardiovascular Risk Assessment: Assess overall ASCVD risk using clinical history and appropriate risk-prediction tools.
- Advanced Lipid Testing: Lp(a) measurement is recommended at least once in adulthood, while apoB may be useful in selected patients, particularly when triglycerides are elevated, diabetes is present, or residual cardiovascular risk needs further clarification.
- Assessment of Secondary Causes: Blood tests may identify conditions that contribute to dyslipidemia, including diabetes, hypothyroidism, kidney disease, liver disease, and other metabolic disorders.
- Imaging Tests:
- Coronary Artery Calcium (CAC) Scoring: Consider CT-based CAC scoring in selected adults when the need for preventive lipid-lowering treatment remains uncertain after clinical risk assessment.
- Carotid Ultrasound: Consider in selected patients when assessing vascular disease is clinically relevant, although it is not routinely required for all patients with dyslipidemia.
- Echocardiography: Consider when symptoms or findings suggest structural or functional heart disease.
- CT Coronary Angiography: Consider when clinically indicated for suspected coronary artery disease, rather than as a routine dyslipidemia test.
- Additional Imaging: Recommend vascular imaging, stress testing, or other cardiovascular investigations based on symptoms, cardiovascular risk, and suspected complications.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Dyslipidemia patients in Malaysia. These Services include:
- Exercise and Physical Activity: Regular aerobic and resistance exercise can support healthy lipid levels, cardiovascular fitness, weight management, and overall cardiovascular health.
- Cardiovascular Rehabilitation: Patients with established cardiovascular disease may benefit from structured cardiac rehabilitation incorporating exercise, education, nutrition, and risk-factor management.
- Treatment generally involves lifestyle changes and lipid-lowering medicines selected according to the specific lipid abnormality and the patient's overall cardiovascular risk. Statins commonly lower LDL cholesterol. If additional lowering is needed, a clinician may consider medicines such as ezetimibe or other non-statin therapies. Specific treatments may also be required for severe hypertriglyceridemia or inherited lipid disorders. Bariatric surgery may be considered separately for eligible patients with obesity, but it is not a routine treatment for dyslipidemia itself
Instantly Connect with our Specialists
Hospitals for Dyslipidemia in Malaysia
ParkCity Medical Centre
Kuala Lumpur, Malaysia
In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.
Bukit Tinggi Medical Centre
Kuala Lumpur, Malaysia
As a tertiary care hospital, Bukit Tinggi Medical Centre (BTMC) is committed to providing high-quality, reasonably priced healthcare.
With a focus on patient care and a team of committed medical professionals and personnel, we want to realize our ambition of becoming Klang's go-to healthcare provider. Orthopedics, neurosurgery, cardiac surgery, obstetrics and gynecology, pediatrics and rehabilitation, aesthetic surgery, and other specialties are all part of our multidisciplinary team approach. Additionally, BTMC has a Health Screening Center that provides a range of health packages to meet the requirements of diverse patient types.
Damansara Specialist Hospital 2 (DSH2), Kuala Lumpur
Kuala Lumpur, Malaysia
- The KPJ Damansara Specialist Hospital 2 in Malaysia is a multidisciplinary centre providing care across a range of specialities, including cardiology, oncology, orthopaedics, neurology, gastroenterology, women’s health, paediatrics, and minimally invasive surgery. The hospital uses evidence-based treatment methods and has advanced diagnostic and rehabilitation capabilities, and provides patient-centred care through experienced specialists and the latest technology. The hospital has an experienced team that provides comprehensive additional services to patients from other countries, including pre-therapy planning, recovery, and rehabilitation assistance, making it a leader in private healthcare in Malaysia.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Malaysia for Dyslipidemia Treatment?
- Experienced Cardiometabolic Specialists: Major Malaysia hospitals may provide access to cardiologists, endocrinologists, lipid specialists, internal medicine physicians, and other specialists involved in managing complex lipid disorders.
- Advanced Lipid Testing: Many centres offer comprehensive lipid profiles, Lp(a) and apoB testing, metabolic evaluation, and assessment for inherited or secondary causes of dyslipidemia when clinically indicated.
- Modern Cardiovascular Risk Assessment: Selected centres may offer CAC scoring, cardiovascular imaging, advanced risk assessment, and evaluation for established or subclinical cardiovascular disease.
- Comprehensive Treatment Options: Patients may have access to lifestyle programmes, statins, non-statin lipid-lowering medicines, therapies for severe hypertriglyceridemia, and specialist management of familial lipid disorders.
- International Patient Support: Major hospitals in Malaysia may provide medical-record review, specialist coordination, treatment scheduling, visa and travel assistance, accommodation support, interpretation, and follow-up services for international patients.
Frequently Asked Questions
Dyslipidemia generally does not have a fixed recovery period because it is usually a chronic metabolic condition rather than an acute illness. Cholesterol and triglyceride levels may improve within weeks to months after lifestyle changes or medication, but long-term treatment and monitoring may be needed to maintain lipid control and reduce cardiovascular risk.
Yes. Dyslipidemia itself generally does not interfere with walking. Regular walking and other forms of physical activity can support cardiovascular health and help improve some lipid abnormalities. People with known cardiovascular disease, chest pain, severe breathlessness, or other exercise limitations should discuss an appropriate activity level with their healthcare professional.
Many advanced hospitals in Malaysia provide comprehensive lipid testing, cardiovascular risk assessment, Lp(a) and apoB testing when appropriate, and access to modern lipid-lowering medicines. Selected centres may also offer coronary artery calcium scoring and cardiovascular imaging for patients who require further risk assessment.
Many major Malaysia hospitals have international-patient departments that may assist with medical records, specialist consultations, treatment coordination, visa documentation, travel arrangements, accommodation, interpretation, and follow-up care. Services vary between hospitals.
Consider a cardiologist, endocrinologist, lipid specialist, or internal medicine physician experienced in managing your specific lipid abnormality and cardiovascular risk profile. For complex or inherited dyslipidemia, consider a centre with advanced lipid testing, cardiovascular risk assessment, genetic evaluation (when appropriate), and long-term specialist follow-up.
The success rate for dyslipidemia treatment because outcomes depend on the type of lipid abnormality, baseline levels, cardiovascular risk, underlying causes, treatment used, and individual response. Appropriate lifestyle changes and lipid-lowering medicines can substantially reduce LDL-C and other atherogenic lipid levels in suitable patients. The main treatment goal is long-term cardiovascular risk reduction rather than a single measure of success.
Many tertiary Malaysia hospitals have cardiologists, endocrinologists, diabetologists, internal medicine physicians, and other specialists experienced in managing dyslipidemia and its associated cardiovascular and metabolic conditions. Patients with familial or complex lipid disorders may benefit from multidisciplinary specialist care.
The risks depend on the treatment used. Statins and other lipid-lowering medicines can cause medication-specific adverse effects, although many patients tolerate them well. Some medicines require monitoring of liver enzymes, kidney function, muscle symptoms, or other parameters depending on the drug. Lifestyle interventions are generally safe when tailored appropriately, while cardiovascular procedures or surgery carry separate procedure-related risks.
Dyslipidemia does not generally cause physical deformities. However, severe inherited lipid disorders can sometimes cause visible cholesterol deposits such as tendon xanthomas or xanthelasma. More importantly, prolonged untreated dyslipidemia can contribute to atherosclerosis and cardiovascular complications that may cause long-term disability.
Yes, particularly when dyslipidemia is associated with cardiovascular disease, diabetes, obesity, or other chronic conditions. Dyslipidemia itself is often asymptomatic, but long-term cardiovascular complications can affect physical activity, independence, work, and daily functioning. Effective lipid management can help reduce the risk of these complications.
Yes. Persistently elevated atherogenic lipoproteins can contribute to plaque formation and increase the risk of coronary artery disease, heart attack, stroke, and peripheral artery disease. Severe hypertriglyceridemia can also increase the risk of acute pancreatitis. Risk depends on the lipid abnormality, its duration, and the presence of other cardiovascular risk factors.
Prevention and long-term management include eating a heart-healthy diet, maintaining a healthy body weight, exercising regularly, avoiding tobacco, limiting excess alcohol intake, and managing conditions such as diabetes and hypothyroidism. Regular lipid screening can help identify abnormalities early, particularly in people with a family history or other cardiovascular risk factors.
Dyslipidemia can affect people of all ages, but risk is higher in people with a family history of lipid disorders or premature cardiovascular disease, obesity, physical inactivity, diabetes, hypothyroidism, chronic kidney disease, certain liver conditions, or specific medication exposures. Some inherited disorders, such as familial hypercholesterolemia, can cause very high LDL-C levels from a young age.
Reviewer
Dr. Ashish George
Gastroenterologist
18 Years of Experience
Dr. Ashish George is one of the leading names in HPB surgery & liver transplantation and has about 18+ years of experience.He is a principal consultant & unit head of liver transplant at Fortis Shalimar Bagh. View More
Last Reviewed - January 2026